Form D · Biotechnology

Flow Forward Medical, Inc.

Fairway, KS · CIK 0001595721

Offering snapshot reported Oct 27, 2020 · SEC filing

Reported sold
Yet to sell
Indefinite offering
Investors reported
0
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Yet to occur
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 27, 2020AmendmentYet to sellNo comparison0SEC filing
Oct 27, 2020Amendment$300,000No comparison5SEC filing
May 29, 2020InitialYet to sellNo comparison0SEC filing
Mar 17, 2020InitialYet to sellNo comparison0SEC filing
Jan 3, 2014InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-363016
The offering is now closed. The Issuer was merged out of existence on June 8, 2020

Source: Form D, filed Oct 27, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Kurt Dasse Director
F. Nicholas Franano Executive
Frank Nicholas Franano Director, Executive
Jenny Martin Executive
James M. Schultz Director
Jeff Weinrich Director
William P. Whitaker Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
4220 Shawnee Mission Parkway Suite B350
Fairway, KS, 66205